Home » Topics » Disease categories and therapies » Urology

Urology
RSS

RenaGel results announced at Harvard seminar

May 17, 1996

Zaprinast claimed for treatment of renal failure

May 17, 1996

Schering-Plough adenosine A1 receptor ligand described for renal failure

May 17, 1996

Disappointing results attained in Recordati/SKB BPH trial

May 17, 1996

TBC-11241 protects against dye-induced hemodynamic changes in rats

May 10, 1996

L-Arginine potential for treating interstitial cystitis

May 10, 1996

Terflavoxate development halted

May 10, 1996

Terazosin and finasteride go head-to-head in VA study

May 10, 1996

Novel non-pharmaceutical approach to BPH presented

May 10, 1996

Terazosin and finasteride reduce PSA serum levels: Implications for diagnostic testing

May 10, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...